Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 26

    1.

    Targeting protein-trafficking pathways alters melanoma treatment sensitivity.

    Huang ZM, Chinen M, Chang PJ, Xie T, Zhong L, Demetriou S, Patel MP, Scherzer R, Sviderskaya EV, Bennett DC, Millhauser GL, Oh DH, Cleaver JE, Wei ML.

    Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):553-8. Epub 2011 Dec 27.

    PMID:
    22203954
    [PubMed - indexed for MEDLINE]
    2.

    Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.

    Aarntzen EH, Srinivas M, De Wilt JH, Jacobs JF, Lesterhuis WJ, Windhorst AD, Troost EG, Bonenkamp JJ, van Rossum MM, Blokx WA, Mus RD, Boerman OC, Punt CJ, Figdor CG, Oyen WJ, de Vries IJ.

    Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18396-9. Epub 2011 Oct 24.

    PMID:
    22025695
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.

    Kratky W, Reis e Sousa C, Oxenius A, Spörri R.

    Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17414-9. Epub 2011 Oct 10.

    PMID:
    21987815
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.

    Meyer C, Sevko A, Ramacher M, Bazhin AV, Falk CS, Osen W, Borrello I, Kato M, Schadendorf D, Baniyash M, Umansky V.

    Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17111-6. Epub 2011 Oct 3.

    PMID:
    21969559
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.

    Feige E, Yokoyama S, Levy C, Khaled M, Igras V, Lin RJ, Lee S, Widlund HR, Granter SR, Kung AL, Fisher DE.

    Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E924-33. Epub 2011 Sep 26.

    PMID:
    21949374
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.

    Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, Xu Y, Pogoriler E, Terzulli SL, Kuk D, Panageas KS, Ritter G, Sznol M, Halaban R, Jungbluth AA, Allison JP, Old LJ, Wolchok JD, Gnjatic S.

    Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16723-8. Epub 2011 Sep 20.

    PMID:
    21933959
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes.

    Speiser DE, Wieckowski S, Gupta B, Iancu EM, Baumgaertner P, Baitsch L, Michielin O, Romero P, Rufer N.

    Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15318-23. Epub 2011 Aug 29.

    PMID:
    21876175
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.

    Choi KY, Chang K, Pickel JM, Badger JD 2nd, Roche KW.

    Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15219-24. Epub 2011 Sep 6.

    PMID:
    21896768
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.

    Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P, Zhang LJ, Thorne RF, Wilmott J, Scolyer RA, Hersey P, Zhang XD, Wu M.

    Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15840-5. Epub 2011 Sep 6.

    PMID:
    21896753
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    An antigenic peptide produced by reverse splicing and double asparagine deamidation.

    Dalet A, Robbins PF, Stroobant V, Vigneron N, Li YF, El-Gamil M, Hanada K, Yang JC, Rosenberg SA, Van den Eynde BJ.

    Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):E323-31. Epub 2011 Jun 13.

    PMID:
    21670269
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells.

    Paganin-Gioanni A, Bellard E, Escoffre JM, Rols MP, Teissié J, Golzio M.

    Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10443-7. Epub 2011 Jun 13.

    PMID:
    21670256
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.

    Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L, Polley EC, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H, Hearing VJ.

    Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6597-602. Epub 2011 Apr 1.

    PMID:
    21460252
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity.

    Zhang D, Hedlund EM, Lim S, Chen F, Zhang Y, Sun B, Cao Y.

    Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4117-22. Epub 2011 Feb 18.

    PMID:
    21367692
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Eradication of melanomas by targeted elimination of a minor subset of tumor cells.

    Schmidt P, Kopecky C, Hombach A, Zigrino P, Mauch C, Abken H.

    Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2474-9. Epub 2011 Jan 31.

    PMID:
    21282657
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

    Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO.

    Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1379-84. Epub 2011 Jan 10.

    PMID:
    21220330
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

    Villares GJ, Zigler M, Dobroff AS, Wang H, Song R, Melnikova VO, Huang L, Braeuer RR, Bar-Eli M.

    Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):626-31. Epub 2010 Dec 27.

    PMID:
    21187389
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.

    Nuber N, Curioni-Fontecedro A, Matter C, Soldini D, Tiercy JM, von Boehmer L, Moch H, Dummer R, Knuth A, van den Broek M.

    Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15187-92. Epub 2010 Aug 9.

    PMID:
    20696919
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells.

    Krieg C, Létourneau S, Pantaleo G, Boyman O.

    Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11906-11. Epub 2010 Jun 14. Erratum in: Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):345.

    PMID:
    20547866
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells.

    Das SK, Sokhi UK, Bhutia SK, Azab B, Su ZZ, Sarkar D, Fisher PB.

    Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11948-53. Epub 2010 Jun 14.

    PMID:
    20547861
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis.

    Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O'Rourke K, Chan S, Dong J, Qu Y, Roose-Girma M, Dixit VM, Monack DM.

    Proc Natl Acad Sci U S A. 2010 May 25;107(21):9771-6. Epub 2010 May 10.

    PMID:
    20457908
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk